Product
Prasugrel or Ticagrelor
2 clinical trials
3 indications
Indication
Coronary Artery DiseaseIndication
Acute Coronary SyndromeIndication
Atrial FibrillationClinical trial
Tailoring Bleeding Reduction Approaches in Patients Undergoing Percutaneous Coronary Interventions: Comparative Pharmacodynamic Effects of Potent P2Y12 Inhibitor Monotherapy Versus Dual Antiplatelet Therapy De-escalationStatus: Recruiting, Estimated PCD: 2024-10-15
Clinical trial
Escalated Single Platelet Inhibition for One Month Plus Direct Oral Anticoagulation in Patients With Atrial Fibrillation and acUte coRonary Syndrome Undergoing percutaneoUS Coronary InterventionStatus: Recruiting, Estimated PCD: 2024-12-16